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Abstract.  The subcellular distribution of the 1,4- 
dihydropyridine receptor was determined in rabbit 
skeletal muscle in situ by immunofluorescence and im- 
munoelectron microscopy. Longitudinal and transverse 
cryosections (5-8  #m) of rabbit gracilis muscle were 
labeled with monoclonal antibodies specific against 
either the otrsubunit (170,000-D polypeptide) or the 
~-subunit (52,000-D  polypeptide) of the 1,4-dihydro- 
pyridine receptor by immunofluorescence labeling. In 
longitudinal sections, specific labeling was present 
only near the interface between the A- and I-band 
regions of the sarcomeres. In transverse sections, 
specific labeling showed a hexagonal staining pattern 
within each myofiber however,  the relative staining in- 
tensity of the type II (fast)  fibers  was judged to be 
three- to fourfold higher than that of the type I (slow) 
fibers.  Specific  immunofluorescence labeling of the 
sarcolemma was not observed in either longitudinal or 
transverse sections. These results are consistent with 
the idea that the t~rsubunit and the/3-subunit of the 
purified 1,4-dihydropyridine receptor are densely dis- 
tributed in the transverse tubular membrane. 
Immunoelectron microscopical localization with a 
monoclonal antibody to the c~,-subunit of the 1,4-dihy- 
dropyridine receptor showed that the 1,4-dihydropy- 
ridine receptor is densely distributed in the transverse 
tubular membrane. Approximately half of these were 
distributed in close proximity to the junctional region 
between the transverse tubules and the terminal cister- 
nae. Specific  labeling was also present in discrete foci 
in the subsarcolemmal region of the myofibers.  The 
size and the nonrandom distribution of these foci in 
the subsarcolemmal region support the possibility that 
they correspond to invaginations from the sarcolemma 
called caveolae.  In conclusion, our results demonstrate 
that the  1,4-dihydropyridine receptor in skeletal muscle 
is localized to the transverse tubular membrane and 
discrete foci in the subsarcolemmal region, possibly 
caveolae but absent from the lateral portion of the 
sarcolemma. 
V 
OLTAGE-SENSITIVE Ca 2+  channels  are  present  in 
smooth,  cardiac,  and skeletal muscle as well as in 
neuronal and endocrine cells (35, 43). The 1,4-dihy- 
dropyridines are potent blockers of the L-type voltage-sensi- 
tive Ca  2+ channels  (14). Electrophysiological  studies have 
shown that  1,4-dihydropyridine-sensitive Ca  2+ channels are 
localized to the transverse tubule membrane in adult skeletal 
muscle (37). Binding studies have shown that high affinity 
receptors  for the 1,4-dihydropyridines are enriched  in iso- 
lated transverse tubular  membranes  (9) and isolated triads 
(25) from skeletal muscle, but constitute only 0.1-0.8 % of  the 
total protein in purified transverse tubular membrane vesi- 
cles (4, 9). Recently, it has been shown that dihydropyridines 
also inhibit charge movement in the transverse tubular mem- 
brane  and thus excitation-contraction  coupling  in skeletal 
muscle (36). 
The molecular properties of the dihydropyridine receptor 
from skeletal muscle  has been  extensively studied during 
the last  few years  and reviewed recently  (3,  4,  12). The 
purified dihydropyridine receptor from skeletal muscle has 
been shown to contain at least four polypeptide components: 
ot,-subunit, c~2-subunit, ~subunit, and 3,-subunit. The c~- 
subunit has an apparent molecular mass of 155-200 kD on 
SDS-PAGE under both nonreducing and reducing conditions 
and contains binding sites for dihydropyridine and arylalkyl- 
amine Ca  ~÷ channel blockers.  The primary amino acid se- 
quence of the ct~-subunit is consistent with it being the ion 
conduction  and voltage-sensing unit of the  Ca  2÷  channel. 
The ot2-subunit has an apparent molecular mass of 165-175 
kD  under nonreducing  conditions  and  135-150 kD  after 
reduction of disulfide bonds. The change in molecular mass 
is possibly due to dissociation of  one or more disulfide linked 
proteins  of 24-33  kD  which have been  referred to as the 
tS-subunits. The B-subunit of the dihydropyridine receptor 
has an apparent molecular mass of 50-61 kD on SDS-PAGE 
which is insensitive to reduction. The a,-subunit and B-sub- 
unit are substrates for various protein kinases. The -y-subunit 
of the dihydropyridine receptor is a glycoprotein with an ap- 
parent molecular mass of 30-33  kD on SDS-PAGE. A stoi- 
chiometric ratio of 1:1:1:1 has been obtained for the or,, c~2, 
B, and '),-subunits, respectively, after taking into considera- 
tion the glycoprotein nature of the c¢2-subunit. This obser- 
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components of the 1,4-dihydropyridine receptor. 
In this paper, we report on the subcellular distribution of 
the o~- and/~-subunits of the purified  1,4-dihydropyridine 
receptor of adult rabbit skeletal muscle as determined by 
immunofluorescence  and  immunoelectron  microscopical 
studies. 
Materials and Methods 
Monocional Antibodies to the 1,4-Ih'hydropyridine 
Receptor 
The mAbs to the  170,000-D (t~l) and the 52,000-D  (~) subunits of the 
1,4-dihydropyridine receptor from rabbit skeletal muscle were prepared and 
characterized as previously  described (24, 25). Immunoblotting was per- 
formed according to the methods of Towbin (42) using 5% non-fat dry milk 
in PBS (BLOTTO)  for blocking and washing of the immunoblots as de- 
scribed (15). Determination of the immunoglobulin class of the rnAbs was 
carded out by immunoditfusion according to the procedure of Ouchterlony 
(29). Each of the mAbs was immunoditfused against monospecific antibod- 
ies to mouse IgGi, IgG2a, IgG2b, IgG3, and IgM. mAb IIID5 to the t~t-sub- 
unit of the 1,4-dihydropyridine  receptor used for immunoelectron micros- 
copy  was purified from the mouse ascites  fluid by DEAE-Affi  Gel Blue 
chromatography  (1). 
Monoclonal Antibodies to the CaZ÷-ATPase of the 
Sarcoplasmic Reticulum 
mAb IID8 to the Ca2+-ATPase from canine cardiac sarcoplasmic reticulum 
and mAb IIHll to the Ca2+-ATPase of rabbit skeletal sareoplasmic reticu- 
lure used in this study were prepared, purified, and characterized as previ- 
ously described (18). 
Preparation of Skeletal Muscle Extract, Triads, and 
Transverse  Tubule Membranes 
The extract represents the supornatant  obtained from tissue homogenates 
during the preparation of triads.  Triads were prepared as described by 
Mitchell et al. (28) with slight modification (39). Transverse tubular mem- 
branes were prepared by the method of Rosemblatt et al. (34). Protein con- 
centrations were determined by the method of Lowry (26) as modified by 
Peterson (31) using BSA as a standard.  SDS-PAGE on 3-12% gradiem gels 
was performed by the method of Laemmli (23). 
Dissection, Fixation, and Sectioning 
Fixed and unfixed bundles of skeletal muscle fibers from rabbit gracilis and 
psoas muscle were prepared as previously described (20). Briedfly, bundles 
of myofibers from rabbit  gracilis or psoas muscle were dissected and quickly 
frozen  in liquid nitrogen-cooled isopentane.  Bundles of myofibers  to be 
fixed were dissected  from rabbit gracilis or psoas muscle and immediately 
tied to applicator sticks (for chemical fixation) or stainless steel loops (for 
cyrofixation) at 100-120% of their rest length and allowed to recover for 30 
rain in a modified Krebs-Henseleit buffer (145 mM NaCI, 2.6 mM KCI, 5.9 
mM CaCI2, 1.2 mM MgSO4, 25 mM NaI-ICO3, and 10 mM glucose,  satu- 
rated with a mixture of 95% 02 and 5% C02). The bundles of myofibers 
to be used for immunofiuorescence  studies  were fixed for 3 h in ice-cold 
2% paraformaldehyde  in 0.1 M sodium cacodylate (pH 7.4). Sucrose infu- 
sion, storage, and cryosectioning  (6-8 ttm) were carried out as previously 
described. The bundles of myofibers to be used for immunocolloidal gold 
labeling were cryofixed,  freeze-dried,  and low temperature embedded in 
Lowicryl  K4M as previously  described (Procedure II [17]) except that 10 
rain before freezing, the Krebs-Henseleit buffer was changed to also include 
4%  polyvinyl  pyrrolidone (Sigma  Chemical Co.,  St.  Louis,  MO)  as  a 
cryoprotectant  (19). Briefly the bundles of myofibers were cryofixed using 
the "Gentleman Jim" freezing device (Ted Pella, Tustin, CA) as described 
by Philips and Boyne (32). The cryofixed tissue was then quickly transferred 
to liquid nitrogen and stored overnight. Freeze-drying was carried out at low 
temperature in a glass cryosorption pump (5, 27). Infiltration and embed- 
ding of the cryofixed, freeze-dried tissue in ~icryl  K4M was performed 
according to the procedure of Chiovetti et al. (5, 6) as modified by Jorgensen 
and McGuffee (17). Thin sections (60-80 nm) were collected on nickel grids 
coated with formvar. 
Immunofluorescence Labeling 
Immunofluorescence  staining of cryosections from unfixed rabbit gracilis 
was carded out as previously described (20). The sections were first labeled 
with one of the following rnAbs: HD8 to Ca2+-ATPase of canine cardiac 
sarcoplasmic reticulum; HHll to Ca2+-ATPase of rabbit skeletal sarcoplas- 
mic reticulum; HID5 and IICI2, to the ~l-subunit of the 1,4-dihydrol~ri- 
dine receptor; and VD21 to the/3-subunit of the 1,4-dihydropyridine recep- 
tor. The secondary antibody was F(ab')2 fragments of affinity-purified goat 
anti-mouse IgG conjugated to ~  (CooperBiomedical  Inc., Malvern, 
PA). It was used at a dilution of 1:20. The fluorescence  photographs were 
taken with a Zeiss photomicroscope provided with an Epi-fluorescence  at- 
tachment and a phase-contrast condenser using Kodak Tri-X pan film. 
Immunotluorescence staining of cryosections from fixed rabbit gracilis 
muscle were carded out as described for cryosections  from unfixed rabbit 
gracilis muscle,  except that the secondary antibody used above was sub- 
stituted with a two-step incubation described below. After incubation with 
the primary antibodies, cryosections  were washed in PBS (pH 7.4) and then 
incubated for 30 rain with a  1:25 dilution of biotin conjugated  to affinity- 
purified F(ab')2 fragments of rabbit anti-mouse IgG (Jackson Laboratories, 
PA). Subsequently the sections were again washed in PillS (pH 7.4) and in- 
cubated for 30 rain with a  hi00 dilution of FITC-conjugated  streptavidin 
(Jackson Immuno Research  Laboratories,  Inc., Avondale, PA). Finally the 
sections were washed and mounted as previously described (20). 
Histochemicai Staining 
Serial transverse sections of unfixed rabbit gracilis muscles were stained for 
myosin ATPase after alkaline preincubations (pH 10.4) as described by Guth 
and Samaha (13). This method specifically labels the myosin ATPase of  only 
fast skeletal  muscle fibers. 
ImmunocoUoidai Gold Labeling 
Immunocolloidai gold labeling of thin sections of cryofixed,  frceze-dried, 
and Lowicryl K4M-embedded rabbit skeletal muscle was carried out as pre- 
viously described (16, 17) except for the modification  outlined below. 
The sections were first labeled with DEAE-Affi-Blue gel-purified mAb 
IIID5 to the ,vFsubunit of the 1,4-dihydropyridine  receptor (15 ttg/ml in 
PBS pH 7.4).  Then an afffinity-purified rabbit anti-mouse (F¢ fragment) 
gamma globulin (Jackson Immuno Research Laboratories Inc.) was used at 
25 ttg/ml in PBS containing 3 % BSA. Finally the sections were incubated 
with affinity-purified goat anti-rabbit gamma globulin-colloidal gold con- 
jugate (3-7 nm) at 0.5 mg/ml PBS containing 3 % BSA 0anssen Pharmaceub 
ica,  Beerse,  Belgium). 
To assess the immunolabeling specificity of the thin sections of Lowicryl 
K4M-embedded tissue,  mouse gamma globulin purified from preimmune 
serum (10 tzg/ml PBS) was substituted for rnAb IIID5 in the immunolabeling 
procedure.  After immunolabeling, the sections were first stained for 15 s 
in saturated uranyl acetate in 50% ethanol (6) and then for 15 s in lead ci- 
trate. The sections were examined in a Hitachi 7000 transmission electron 
microscope. 
Ultrastructure of Cryofixed 7issue 
To assess the preservation of the ultrastructural features of the cryofixed and 
freeze-dried skeletal muscle tissue used for the immunoelectron microscop- 
ical studies, some of these tissues were vapor osmicated and then embedded 
in Spurt resin, as described by McGuffee et al. (27). Thin sections were 
stained with 2% uranylacetate  followed by lead citrate,  according to stan- 
dard procedures,  and examined in a Hitachi 7000 transmission electron mi- 
croscope. 
Results 
Characterization of mAbs to the at1- and the 
B-Subunits of the 1,4-Dihydropyridine Receptor 
It was previously shown by immunoblotting and immunopre- 
cipitation experiments that mAb VD2t binds specifically to 
The Journal of Cell Biology, Volume 109, 1989  136 Figure L Coornassie Blue and immunoblot staining of rabbit skeletal muscle extract and membrane fractions. Rabbit skeletal muscle 
extract (lanes 1), light sarcoplasmic reticulum membranes (lanes 2), triads (lanes 3), and transverse tubular membranes (lanes 4) were 
prepared as described in Materials and Methods and separated on SDS-PAGE (30 #g/lane) followed  by Coomassie blue staining or immu- 
noblotting with monoclonal antibodies. A is a Coomassie blue-stained gel, B, C, and D are immunoblots of the gel stained with mAbs 
IIC12, IIID5, and VD21, respectively. 
the fl-subunit (52,000 D) of the 1,4-dihydropyridine receptor 
and that mAbs IIC12 and HID5 bind specifically to the ar 
subunit (170,000 D) of the 1,4-dihydropyridine receptor. In 
the present study, the specificity of these antibodies toward 
the at- and fl-subunits of the  1,4-dihydropyridine receptor 
was further demonstrated by their ability to bind only one 
polypeptide band on immunoblots of extracts from rabbit 
skeletal muscle (Fig.  1, A-D, lanes/). The mAb VD2~ faint- 
ly stains a band in skeletal muscle extract (Fig. 1 D, lane 1) 
that is difficult  to visualize after photography. Both of  the im- 
munoreactive polypeptides are relatively enriched in isolated 
triads (Fig.  1,  lanes 3) and transverse tubular membranes 
(lanes 4) and relatively depleted in light sarcoplasmic reticu- 
lum membranes (lanes 2). 
Distribution of the ~1- and the B-Subunits of the 
1,4-Dihydropyridine Receptor in 1)pc I (Slow) and 
1)pe H (FasO Rabbit Gracilis Muscle 
Serial transverse cyrosections from adult rabbit gracilis mus- 
cle containing a mixture of type I (slow) and type II (fast) 
myofibers were either labeled with mAb VD2~ (anti-/3-sub- 
unit) (Fig. 2 a) or with mAb IIC12 (anti-arsubunit) (Fig. 
2 b) subunits of the 1,4-dihydropyridine receptor of rabbit 
skeletal muscle. To determine the fiber type distribution, ad- 
ditional serial cryosections were also stained with monoclo- 
nal antibodies specific for Ca2+-ATPase of the sarcoplasmic 
reticulum of either type I (slow) fibers (mAb IID8, Fig. 2 d) 
or  type II  (fast)  fibers  (mAb  IIHll,  Fig.  2  e)  (18),  and 
histochemically stained for the type II fiber marker alkali- 
stable actomyosin ATPase (Fig. 2f) (13). One class of myo- 
fibers were weakly labeled with both mAb VD2, and mAb 
IIC12 and corresponded to the type I (slow) fibers. A second 
class  of myofibers were  strongly labeled  with both  mAb 
VD2~ and with mAb IIC12 and corresponded to 95% of the 
type II (fas0 fibers. A third class of myofibers constituting 
,05%  of the total fibers was also observed.  This class of 
fibers  was characterized by being more  intensely labeled 
with mAb VD2,  than the majority of the strongly labeled 
type II fibers but less intensely labeled with mAb IIC12 than 
the majority of the strongly labeled Type II fibers. Immu- 
nofluorescence labeling with another mAb IIID5 specific for 
the a~-subunit of the  1,4-dihydropyridine receptor (Fig.  2 
c) showed that 95 % of the type II (fast) fibers also strong- 
ly labeled by mAb VD2~ (anti-/~-subuni0 (Fig. 2 a, star) 
and mAb IIC12 (anti-arsubunit) (Fig. 2 b, star) were also 
strongly labeled with mAb IIID5 (Fig. 2 c, star) and that all 
type I (slow)  fibers were weakly labeled with this antibody 
(Fig. 2 c, solid circle). However the intensity of labeling of 
the remaining 5 % of type II (fast) and the type I (slow) fibers 
by mAb IIID5 was weak and indistinguishable from each 
other. The immunochemical and immunocytochemical  char- 
acteristics of the mAbs used in the present report is summa- 
rized in Table I. 
Comparison between the Distribution of the ~1- and 
the B-Subunits of  the 1,4-Dihydropyridine  Receptor in 
Skeletal Muscle Fibers 
The studies described below were limited to type II (fast) 
myofibers. Examination of  transverse sections of  type II myo- 
fibers in gracilis muscle after immunolabeling with either 
mAb VD2~ (anti-/~-subunit) (Fig. 3 a) or with mAb IIID5 
(anti-a,-subunit)  (Fig.  3 f)  showed  a  polygonal staining 
pattern throughout the cytoplasm. The distance between the 
centers of neighboring polygons ranged from 1.1 to 1.5 #m. 
In contrast, the intensity of labeling of the sarcolemma was 
indistinguishable from that of the extracellular space. In lon- 
gitudinal cyrosections of  type II myofibers from fixed gracilis 
muscle,  regular  immunofluorescence staining  with either 
mAb VD2~ (anti-/~-subunit) subunit (Fig. 3, c, d, and e) or 
with mAb IIID5 (anti-a~-subunit) (Fig. 3, h, i, and j) ap- 
Jorgensen et al. immunolocalization  of Dihydropyridine Receptor  137 Figure 2.  Distribution of the 52,000- and the 170,000-D  subunit of the  1,4-dihydropyridine receptor in type I  (slow) and type II (fast) 
myofibers of rabbit gracilis muscle. Serial transverse cryosections of unfixed rabbit gracilis muscle were immunofluorescently labeled with 
mAb VD2t  (a) to the ~-subunit of the  1,4-dihydropyridine receptor, with mAb IIC12 (b) and mAh IIID5 (c) to the at-subunit of the 
1,4-dihydropyridine receptor, with mAb IID8 (d) and mAb IIHll (e), respectively specific for the SR-Ca:+-ATPase  of the type I (slow) 
and type II (fast) myofibers of rabbit skeletal muscle and histochemically stained for alkali-stable myosin ATPase (f), a marker for type 
II (fast) myofibers. Note that three classes of fibers can be distinguished after labeling with either mAb VD2~ (a), mAb IIC12 (b), or mAb 
IIID5 (c). One class is relatively intensely labeled with all three mAbs (a, b, and c, star); a second class is relatively weakly labeled with 
all three mAbs (a, b, and c, solid circle); a third class is more intensely labeled with mAb VD2~ (a; open circle) but labeled with medium 
and low intensity by mAb IIC12 (b; solid circle) and mAb IIID5 (c; solid circle), respectively. The weakly labeled myofibers (a, b, and 
c, solid circle) correspond to type I (slow) fibers (d,. e, and f, solid circle) while the remaining fibers correspond to type II (fast) fibers 
(d, e, and f, star and open  circle).  Bar, 20 t~m. 
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Monoclonal  lmmuno-t  ImmunoblotN 
antibody  Class*  PPT assay  assay (Mr) 
lmmunocytochernicai labeling of muscle fibers§ 
Type II 
Epitope  95 %  5 %  Type I 
kD 
VD2t  IgGt  +  52 
IIC12  IgG~  +  170 
IIID5  IgGt  +  170 
IID8  ND  115 
IIHI 1  ND  115 
DHPR-subunit  +  +  +  +  +  +  + 
DHPR-subunit  +  +  +  +  + 
DHPR-subunit  + + +  +/- 
Ca2+_ATPase  -  _ 
(cardiac,  slow) 






* Determination of the immunoglobulin class was carried out by immunodiffusion (13). 
The immunoprecipitation assay was performed as previously described (5). 
§ The immunoblot assay was carried out as described in Materials and Methods. 
I1 Fiber typing was determined according to the procedure of Guth and Samaha. 
PPT, precipitation. 
peared as transversely oriented rows of small bright foci. The 
subcellular distribution  of the immunofluorescence labeling 
(Fig.  3, c and h) corresponded to the interphase between the 
A-band and the I-band as observed by viewing the same field 
by phase-contrast  microscopy of skeletal  muscle  (Fig.  3,  b 
and g).  The intensity  of immunofluorescence  of the  sarco- 
lemma was indistinguishable  from that of the extracellular 
space  after  labeling  with  either  mAb  VD2~  (Fig.  3  e)  or 
mAb IIID5 (Fig. 3j). This is especially evident in the A-band 
regions  of the  sarcolemma,  where demarcation  of the  sar- 
colemma is absent. 
lmmunoelectron Microscopical Labeling 
The distribution  of the ot~-subunit and the ~-subunits  of the 
1,4-dihydropyridine receptor in rabbit skeletal muscle fibers 
as determined  by immunofluorescence  labeling  are consis- 
tent with the idea that both subunits of the  1,4-dihydropyri- 
dine receptor are densely distributed in the transverse tubu- 
lar membrane but apparently absent from the sarcolemma. 
Figure 3. Subcellular distribution of the 52,000- and the 170,000-D 
subunits of the 1,4-dihydropyridine receptor in type II myofibers of 
rabbit gracilis muscle.  Unfixed (a and f) and fixed  (2 % parafor- 
maldehyde) (b-e and g-j) adult rabbit gracilis muscle was cryostat 
sectioned transversely (a and f) and longitudinally (b-e and g-j) 
and labeled with mAb (VD20 to the B-subunit (a, c, d, and e) and 
with mAb (IIID5) to the ~l-subunit (f, h, i, and j) of the 1,4-dihy- 
dropyridine receptor purified from the triad subfraction of skeletal 
muscle membranes. In transverse sections (a and f) a polygonal 
staining pattern was observed after labeling with antibodies to ei- 
ther the #-sUbunit  (a)  or the  ot~-subunit (f)  of the  1,4-dihydro- 
pyridine receptor. Specific labeling of the sarcolemma was not ap- 
parent (a and  f). The immunofluoreseence staining pattern in c and 
h were compared with the position of  the A- and 1-bands in the same 
respective fields (mirror image) (b and g) as viewed by phase con- 
trast microscopy. Regular fluorescent staining appeared as small 
bright foei in the interphase between the A- and 1-bands after label- 
ing  with  mAbs to either  the  B-subunit  (c,  d,  and  e)  or the  cq- 
subunit (h, i, and j) of the  1,4-dihydropyridine receptor, however 
the intensity of labeling of the sarcolemma was generally indistin- 
guishable from that of the extracellular space (e and j). Bar, 5 #m. 
Jorgensen et al. Immunolocalization of Dihydropyridine Receptor  139 Figure 4.  Ultrastructural features of longitudinal sections of rabbit skeletal muscle fibers. The tissue was cryofixed, freeze-dried, vapor 
fixed with osmium tetroxide, and embedded in Spurr (see Materials and Methods). A- and I-bands (,4, I in a and c), Z-lines (Z, a-d), 
transverse tubules (T, a-d), longitudinal sarcoplasmic reticulum (L-SR, a-d), terminal cisternae (TG, a, c, and d), sarcolemma (SL, a 
and b), and subsarcolemmal vesicles (SV, b) are easily identified. Despite distortion of the arrangement of myofilaments in the myofibril 
due to ice crystal formation ultrastructurally distinct regions of the SR are well preserved (a, c, and d). Although the diameter of the 
T-tubules is considerably larger than normal the junctional complex between the T-tubules and the terminal cisternae is generally well 
preserved (c and d). Bars: (a and b) 0.2 ttm; (c and d) 0.1 #m. 
To determine more precisely the distribution of the 1,4-di- 
hydropyridine receptor, these studies were extended to in- 
clude the immunoelectron microscopical localization of the 
otm-subunit of the 1,4-dihydrop~dine receptor in rabbit psoas 
muscle. 
Preliminary studies showed that specific immunofluores- 
cence labeling of the ¢x~-subunit of the 1,4-dihydropyridine 
receptor in skeletal muscle was eliminated when 0.3% glu- 
taraldehyde was included in the 2 % paraformaldehyde fixa- 
tion solution.  Since 2%  paraformaldehyde both decreased 
the intensity of labeling and proved inadequate for the ultra- 
structural preservation of intracellular membranes in muscle 
tissue, it was not feasible to use ultrathin frozen sections for 
immunolabeling. The loss of specific labeling after chemical 
fixation may in part be due to the low density of the 1,4-di- 
hydropyridine receptor in the transverse tubules (0.1--0.8  % of 
total protein) (4, 9). 
To optimize the preservation of the antigenicity and the in 
situ  distribution  of the  1,4-dihydropyridine receptor,  the 
muscle tissue to be used for immunoelectron microscopical 
labeling was cryofixed, freeze-dried, and embedded in Lowi- 
cryl K4M (17). Since it is not feasible to osmicate the freeze- 
dried tissue before its low temperature embedding in Lowicryl 
K4M,  visualization of membranes  in  the  immunolabeled 
sections is variable and less than optimal. However, the posi- 
tion of T-tubules (T, Figs. 5, 6, and 7 b), terminal cisternae 
The Journal of Cell Biology, Volume 109,  1989  140 Jorgensen et al. Immunolocalization of Dihydropyridine Receptor  141 The Journal of Cell Biology, Volume  109, 1989  142 Figure 6. Electron micrograph of a longitudinal ultrathin section of rabbit skeletal muscle labeled with mAb IIID5 to the ~xt-subunit of 
the 1,4-dihydropyridine receptor showing two triads. Colloidal gold particles are present over regions of the triads judged to correspond 
to T-tubular membrane (T) and absent from the terminal cisternae (TC) and the myofibrils. Z, Z-line. Bar, 0.1 t~m. 
(TC, Figs.  5, 6, and 7 b), and sarcolemma (SL, Figs.  5, 7, 
and 8) can readily be discerned.  Subsarcolemmal vesicles 
and longitudinal sarcoplasmic reticulum are visualized very 
rarely unless the specimen is osmicated (Fig. 4). 
To make sure that the sarcoplasmic reticulum, the trans- 
verse tubular,  and the sarcolemmal membranes were well 
preserved, although not optimally visualized, some of the 
cryofixed and freeze-dried muscle tissues prepared for em- 
bedding in Lowicryl were instead vapor osmicated and Spurr 
embedded to permit visualization of membranes by positive 
staining. The ultrastructural features of the cryofixed, freeze- 
dried, osmicated, and Spurr-embedded tissue are shown in 
Fig.  4.  Myofibrils are  well preserved (Fig.  4  a).  A-  and 
I-bands (Fig. 4, a and c), as well as Z-lines (Fig. 4) can be 
readily identified. The darkly stained sarcoplasmic reticu- 
lum is well preserved throughout the section. Thus longitu- 
dinal SR (L-SR, Fig. 4) and the terminal cisternae (TU, Fig. 
4, a, c, and d) were easily identified. Although the diameter 
of the T-tubules were enlarged (130-200 nm),  most likely 
due to the hypertonic effect of the cryoprotectant, the T-tu- 
bular membrane was well preserved and closely apposed to 
the junctional sarcoplasmic reticulum (Fig. 4, c and d). The 
sarcolemma (SL,  Fig.  4  b)  aiad subsarcolemmal vesicular 
structures (SE, Fig. 4 b) were also well preserved but only 
clearly visualized in sections obtained from the deeper re- 
gions of a cryofixed  piece of muscle tissue where perpendic- 
ular sections through the sarcolemma can be obtained (Fig. 
4 b). Sections obtained from the surface of the cryofixed tis- 
sue would mainly contain tangentially sectioned sarcolemma 
(Fig. 4 a). 
Considering the fact that the resolution of the triple-lay- 
ered immunocolloidal gold-labeling technique used  is  70 
nm, examination of the distribution of colloidal gold parti- 
cles in rabbit skeletal muscle fibers showed that a majority 
of the gold particles were distributed over and within 35 nm 
of the perimeter of transverse tubules (Figs. 5, 6, and 7 b). 
Of these ~50% were within 35 nm of the junctional region 
between the transverse tubule and the junctional sarcoplas- 
mic reticulum. In addition, discrete clusters of  colloidal gold 
particles were present in the subsarcolemmal region of the 
muscle fibers (Figs. 5, 7, a and c, and 8). Examination of sev- 
eral long sweeps of sarcolemma (Fig. 7, a and b) showed that 
the clusters of colloidal gold particles present in the subsar- 
colemmal region of the cell were distributed in a highly non- 
Figure 5. Electron micrograph of a longitudinal section of cryofixed, freeze-dried, and Lowicryl K4M-embedded rabbit psoas muscle with 
mAb IIID5 specific for the tx,-subunit of the 1,4-dihydropyridine receptor by the triple-layered immunocolloidal gold-staining technique 
described in Materials and Methods section. Most of the colloidal gold particles were distributed over the lumen and the membrane of 
the transverse tubules (T). Occasionally, colloidal gold particles were distributed in the subsarcolemma region of the muscle fiber (thin 
arrow), while the sarcolemma (SL) and the terminal cisternae (/U; thick arrows) were generally labeled at the level of the background. 
Similarly, the myofibrils were also only labeled at the level of the background. Z, Z-line. Bar, 0.1 t~m. 
Jorgensen et al. Immunolocalization of Dihydropyridine Receptor  143 Figure 7. Electron micrographs showing two neighboring stretches of sarcolemma (SL) (a and b) in a longitudinal section of a rabbit skeletal 
myofiber immunolabeled with mAb IIID5 to the ot~-subunit of the 1,4-dihydropyridine  receptor. Small clusters of colloidal gold particles 
are distributed in a highly nonrandom fashion in the subsarcolemmal region of the myofiber. Thus, while a particular stretch of subsar- 
colemma might contain several clusters of colloidal gold particles (a, thin arrows), a neighboring stretch of sarcolemma might contain 
no small clusters of colloidal gold particles in this region (b). However labeling of the transverse tubular membrane (T) present in the 
same section (b) was always observed, c is a higher magnification of the enclosed region shown in a. (TC and thick arrows) terminal cister- 
nae; (Z) Z-line; (SL, arrowheads) sarcolemma. Bar, 0.1 /~m. 
random manner.  Thus while extensive stretches of subsar- 
colemma might lack discrete clusters of gold particles (Fig. 
7 b) neighboring stretches of sarcolemma in the same thin 
section of the same myofiber had a relatively high number 
of clusters per unit length of sarcolemma (Fig. 7 a). In con- 
trast, colloidal gold particles were very sparsely distributed 
over the lateral regions of the sarcolemma (SL, Figs. 5, 7, a 
and b, and 8) (1 colloidal gold particle per 10/~m).  Similarly, 
the myofibrils and the intertibrillar spaces where the sar- 
coplasmic reticulum is densly distributed were labeled at a 
level similar to that of the background (>1 colloidal gold par- 
ticle per  10/xm2). 
Discussion 
The  1,4-dihydropyridine  receptor  has  been  identified  in 
many excitable and nonexcitable tissues by the binding of 1,4- 
dihydropyridines to tissue extracts or isolated membranes (14, 
35, 37, 43). However, the 8ubeellular distribution of this pro- 
tein has not previously been described. This is the first report 
on  the  cellular  and  subcellular  distribution  of  the  1,4- 
dihydropyridine receptor in rabbit skeletal muscle tissue in 
situ using immunocytochemical labeling. 
The immunofluorescence labeling studies show that the 
o~rsubunit of the  1,4-dihydropyridine receptor is  densely 
distributed in the interphase between the A- and I-bands in 
rabbit skeletal myofibers where the transverse tubules are lo- 
cated (10, 11) while apparently absent from the sarcolemma. 
This is in agreement with previous biochemical and phar- 
macological  studies  showing  that  the  1,4-dibydropyridine 
receptor is highly enriched in the isolated T-tubular mem- 
brane (9). Our finding that the distribution of the o~l-subunit 
is indistinguishable from that of the/~-subunit of the 1,4-di- 
hydropyridine receptor at the light microscopic level of reso- 
lution is consistent with the idea that the ~-subunit is also 
confined to the transverse tubular membrane and is an inte- 
gral component of the 1,4-dihydropyridine receptor. 
The results of our immunofluorescence studies of trans- 
The Journal of Cell Biology, Volume  109, 1989  144 Figure 8. Electron micrograph of a longitudinal section of rabbit skeletal muscle immunolabeled with mAb IIID5 to the cq-subunit of the 
1,4-dihydropyridine  receptor and showing  the peripheral region of  this cell. Colloidal gold particles were associated  with vesicular structures 
(thin arrows) present in the subsareolemmal region of the myofiber.  The sarcolemma (SL and arrowheads) was labeled only at the level 
of the background. Bar, 0.1 /zm. 
verse sections of rabbit gracilis muscle suggested that the in- 
tensity of labeling of both the ot,-subunit and the/3-subunit 
is two- to threefold higher in 95 % of the type II (fast) than 
in type I (slow) myofibers. This result might in part be ex- 
plained on the basis of the twofold difference between the 
density of T-tubules  of type II (fast) and type I (slow) myo- 
fibers as previously determined by morphometric analysis 
(8). Furthermore, this result is in good agreement with elec- 
trophysiological studies showing that the nifedipine inhibit- 
able slow Ca  2+ current is threefold higher in fast than that in 
slow skeletal muscle fibers of rat and rabbit (22).  Finally, 
our immunofluorescence studies support the idea that the 
ctrsubunit and the/3-subunit of the 1,4-dihydropyridine re- 
ceptor are present in a constant stoichiometric ratio (24)  in 
at least 95 % of the myofibers of rabbit gracilis muscle. 
If the olrsubunit and the/3-subunit of the 1,4-dihydropyr- 
idine receptor are indeed present in a 1:1 stoichiometric ratio 
as previously reported (24) our finding that 5 % of the type 
H (fast) myofibers are more strongly stained with mAb VD2, 
to the/3-subunit but more weakly stained with mAbs IIC12 
and IHD5 to the a,-subunit supports the possibility that dis- 
tinct isoforms of these two subunits of the 1,4-dihydropyri- 
dine receptor exist. However further studies will be required 
to determine if this is indeed the case. 
The immunoelectron microscopic studies showed that the 
,~-subunit of the  1,4-dihydropyridine receptor  is  densely 
distributed over the transverse tubular membrane. Of these 
approximately half were distributed over the junctional re- 
gion between the T-tubular membrane and the junctional 
sarcoplasmic reticulum.  The results also showed that the 
otrsubunit of the 1,4-dihydropyridine receptor was present 
in discrete clusters in the subsarcolemmal region of skeletal 
myofibers but absent from the lateral regions of the sar- 
colemma. Although it is difficult  to visualize membranes due 
to the specimen preparation procedure used,  the discrete 
clusters of gold particles appeared occasionally to be mem- 
brane bound. We propose that the 1,4-dihydropyridine recep- 
tor containing foci in the subsarcolemmal region are mem- 
brane bound. 
The localization of the 1,4-dihydropyridine receptor to the 
subsarcolemmal region of skeletal muscle by electron mi- 
croscopy appears to be in disagreement with the results of 
the immunofluorescence studies presented here.  This dis- 
crepancy could be explained by the nonuniform distribution 
of the  1,4-dihydropyridine receptor in the subsarcolemmal 
region of skeletal muscle and the limited sensitivity of the 
immunofluorescence technique. Although the  1,4-dihydro- 
pyridine receptor distributes in regular clusters in the subsar- 
colemmal region,  the clusters might not have a  sufficient 
concentration of 1,4-dihydropyridine receptor to permit de- 
tection by immunofluorescence. 
Previously described membrane-bound structures present 
in the subsarcolemmal region of skeletal muscle fibers in- 
clude caveolae (7, 30, 33, 34), transverse tubule openings to 
the sarcolemma (10, 44), junctional sarcoplasmic reticulum 
(40), and longitudinal sarcoplasmic reticulum. Since neither 
the  longitudinal sarcoplasmic  reticulum nor the terminal 
cisternae in the interior regions of the myofiber were labeled 
with antibodies to the tx~-subunit of the 1,4-dihydropyridine 
receptor, it seems unlikely that the colloidal gold-containing 
vesicular  structures  in the  subsarcolemmal  region of the 
myofiber correspond to either of these structures. 
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sarcolemma has been difficult to demonstrate, ultrastructural 
studies  of guinea  pig  (33)  and  frog  skeletal  muscle  (44) 
showed that transverse tubules frequently terminate in caveo- 
lae which in turn are continuous with other caveolae and the 
sarcolemma. However physiological studies by Zampighi et 
al. (44) suggested that only a subgroup of the caveolae are 
connected  with transverse  tubules.  Freeze-fracture  studies 
have shown that caveolae are nonuniformly distributed on the 
cell surface in frog (7) and guinea pig skeletal muscle fibers 
(33).  Since the size, shape, and nonuniform distribution of 
the  cxl-subunit-containing  entities  in  the  subsarcolemmal 
region of rabbit skeletal muscle is similar to that described 
for caveolae (65  ×  80 nm) (7) in other vertebrate  skeletal 
muscles (33,  44)  we propose that they represent caveolae, 
possibly the subgroup of caveolae connecting the transverse 
tubules and the sarcolemma (33, 44). 
The  exact physiological  role of the  1,4-dihydropyridine 
receptor in skeletal muscle remains to be elucidated.  Our 
finding that the ot~-subunit of the 1,4-dihydropyridine  recep- 
tor is present in both the junctional and nonjunctional re- 
gions of the transverse tubular membranes as well as in sub- 
sarcolemmai entities proposed to be caveolae supports  the 
possibility that this receptor has dual functions in skeletal 
muscle.  It has been suggested that the  1,4-dihydropyridine 
receptor functions both as a voltage sensor in excitation-con- 
traction  coupling to release Ca  2+ from the sarcoplasmic re- 
ticulum (36, 38, 41) and as a calcium channel (38, 41).  Our 
finding that approximately half of the 1,4-dihydropyridine  re- 
ceptor labeling  in the transverse  tubular  membranes  is in 
close proximity to and thus potentially capable of communi- 
cating with the junctional sarcoplasmic reticulum membrane 
supports  the hypothesis that these receptors act as voltage 
sensors in excitation-contraction  coupling.  Morphological 
data on transverse tubular membranes indicate that a distinc- 
tive  set  of intramembranous  particles  which are  the  sole 
components of the junctional transverse  tubular membrane 
are present in diamond-shaped clusters that correspond ex- 
actly  in position to the subunits  of the "SR feet" (2).  Our 
results support the contention that these particles are 1,4-di- 
hydropyridine  receptors. Preliminary results  from our labo- 
ratory also suggest that a complex composed of the  1,4-di- 
hydropyridine  receptor and  the ryanodine receptor can be 
isolated. All of these results suggest the presence of a large 
junctional  complex,  consisting  of the  1,4-dihydropyridine 
and the ryanodine receptor,  spanning the triadic junction and 
functioning  in  excitation-contraction  coupling.  Since  the 
1,4-dihydropyridine  receptors in the nonjunctional region of 
the transverse  tubules and in the caveolae are not in close 
proximity to the sarcoplasmic reticulum, it is unlikely that 
these receptors function as a sensor for excitation-contrac- 
tion coupling. One possibility is that they function as calcium 
channels. 
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